A new Janus kinase inhibitor medication, deuruxolitinib (Leqselvi, Sun Pharma UK Limited), has been approved in the UK for the treatment of severe alopecia areata in adult patients. The Medicines and ...
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...
International Alopecia Day, observed on the first Saturday of August every year, aims to raise awareness about alopecia, an autoimmune condition that causes hair loss. This year, the day falls on ...
Earlier this year a new drug to treat severe alopecia - an autoimmune condition that causes hair loss - was given the green light for NHS use. Some are keen to try it, others aren't - and some even ...
Thousands of patients are to benefit after health officials have approved an alopecia treatment for widespread NHS use for the first time. Alopecia UK said that patients have gone without NHS ...
Alopecia Treatment Market– Global Outlook and Forecast 2023-2030 is latest research study released by Allied Market Research evaluating the market risk side analysis, highlighting opportunities and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results